var data={"name":"Disorders of bone","type":"SECTION","numTopics":"11,000","numSpecialties":"over 22","sections":[{"name":"Endocrine disorders","type":"SUBSECTION","items":[{"name":"Bone disease in diabetes mellitus","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-disease-in-diabetes-mellitus"},{"name":"Bone disease with hyperthyroidism and thyroid hormone therapy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-disease-with-hyperthyroidism-and-thyroid-hormone-therapy"},{"name":"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-multiple-endocrine-neoplasia-type-2"},{"name":"Endocrine dysfunction in the nephrotic syndrome","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=endocrine-dysfunction-in-the-nephrotic-syndrome"}]},{"name":"Hereditary disorders","type":"SUBSECTION","items":[{"name":"Approach to therapy in multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-therapy-in-multiple-endocrine-neoplasia-type-2"},{"name":"Classification and genetics of multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-and-genetics-of-multiple-endocrine-neoplasia-type-2"},{"name":"Hereditary hypophosphatemic rickets and tumor-induced osteomalacia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hereditary-hypophosphatemic-rickets-and-tumor-induced-osteomalacia"},{"name":"Osteogenesis imperfecta: Clinical features and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteogenesis-imperfecta-clinical-features-and-diagnosis"},{"name":"Osteogenesis imperfecta: Management and prognosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteogenesis-imperfecta-management-and-prognosis"}]},{"name":"Hyperparathyroidism","type":"SUBSECTION","items":[{"name":"Approach to therapy in multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=approach-to-therapy-in-multiple-endocrine-neoplasia-type-2"},{"name":"Classification and genetics of multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=classification-and-genetics-of-multiple-endocrine-neoplasia-type-2"},{"name":"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-multiple-endocrine-neoplasia-type-2"},{"name":"Hungry bone syndrome following parathyroidectomy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=hungry-bone-syndrome-following-parathyroidectomy"},{"name":"Parathyroid carcinoma","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-carcinoma"},{"name":"Parathyroid cysts","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-cysts"},{"name":"Parathyroid hormone assays and their clinical use","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-hormone-assays-and-their-clinical-use"},{"name":"Parathyroid hormone secretion and action","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-hormone-secretion-and-action"},{"name":"Pathogenesis and etiology of primary hyperparathyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-and-etiology-of-primary-hyperparathyroidism"},{"name":"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=preoperative-localization-for-parathyroid-surgery-in-patients-with-primary-hyperparathyroidism"},{"name":"Primary hyperparathyroidism: Clinical manifestations","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-clinical-manifestations"},{"name":"Primary hyperparathyroidism: Diagnosis, differential diagnosis, and evaluation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-diagnosis-differential-diagnosis-and-evaluation"},{"name":"Primary hyperparathyroidism: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=primary-hyperparathyroidism-management"},{"name":"Refractory hyperparathyroidism and indications for parathyroidectomy in dialysis patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=refractory-hyperparathyroidism-and-indications-for-parathyroidectomy-in-dialysis-patients"}]},{"name":"Multiple endocrine neoplasia syndromes","type":"SUBSECTION","items":[{"name":"Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-clinical-manifestations-and-diagnosis"},{"name":"Multiple endocrine neoplasia type 1: Definition and genetics","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-definition-and-genetics"},{"name":"Multiple endocrine neoplasia type 1: Treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=multiple-endocrine-neoplasia-type-1-treatment"}]},{"name":"Osteomalacia","type":"SUBSECTION","items":[{"name":"Clinical manifestations, diagnosis, and treatment of osteomalacia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-treatment-of-osteomalacia"},{"name":"Epidemiology and etiology of osteomalacia","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-etiology-of-osteomalacia"}]},{"name":"Osteoporosis","type":"SUBSECTION","items":[{"name":"Calcitonin in the prevention and treatment of osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=calcitonin-in-the-prevention-and-treatment-of-osteoporosis"},{"name":"Calcium and vitamin D supplementation in osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=calcium-and-vitamin-d-supplementation-in-osteoporosis"},{"name":"Clinical features and evaluation of glucocorticoid-induced osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-features-and-evaluation-of-glucocorticoid-induced-osteoporosis"},{"name":"Clinical manifestations, diagnosis, and evaluation of osteoporosis in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-men"},{"name":"Clinical manifestations, diagnosis, and evaluation of osteoporosis in postmenopausal women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-diagnosis-and-evaluation-of-osteoporosis-in-postmenopausal-women"},{"name":"Denosumab for osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=denosumab-for-osteoporosis"},{"name":"Epidemiology and etiology of osteoporosis in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-etiology-of-osteoporosis-in-men"},{"name":"Epidemiology and etiology of premenopausal osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-etiology-of-premenopausal-osteoporosis"},{"name":"Evaluation and management of aromatase inhibitor-induced bone loss","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-management-of-aromatase-inhibitor-induced-bone-loss"},{"name":"Evaluation and treatment of premenopausal osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-treatment-of-premenopausal-osteoporosis"},{"name":"Osteoporosis after solid organ or stem cell transplantation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoporosis-after-solid-organ-or-stem-cell-transplantation"},{"name":"Osteoporosis in patients with chronic kidney disease: Diagnosis and evaluation","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoporosis-in-patients-with-chronic-kidney-disease-diagnosis-and-evaluation"},{"name":"Osteoporosis in patients with chronic kidney disease: Management","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoporosis-in-patients-with-chronic-kidney-disease-management"},{"name":"Osteoporotic fracture risk assessment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoporotic-fracture-risk-assessment"},{"name":"Osteoporotic thoracolumbar vertebral compression fractures: Clinical manifestations and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteoporotic-thoracolumbar-vertebral-compression-fractures-clinical-manifestations-and-treatment"},{"name":"Overview of dual-energy x-ray absorptiometry","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry"},{"name":"Overview of the management of osteoporosis in postmenopausal women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women"},{"name":"Parathyroid hormone/parathyroid hormone-related protein analogs for osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=parathyroid-hormone-parathyroid-hormone-related-protein-analogs-for-osteoporosis"},{"name":"Pathogenesis of osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pathogenesis-of-osteoporosis"},{"name":"Pharmacology of bisphosphonates","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=pharmacology-of-bisphosphonates"},{"name":"Prevention and treatment of glucocorticoid-induced osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-and-treatment-of-glucocorticoid-induced-osteoporosis"},{"name":"Prevention of osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=prevention-of-osteoporosis"},{"name":"Risks of bisphosphonate therapy in patients with osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risks-of-bisphosphonate-therapy-in-patients-with-osteoporosis"},{"name":"Screening for osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=screening-for-osteoporosis"},{"name":"Selective estrogen receptor modulators for prevention and treatment of osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=selective-estrogen-receptor-modulators-for-prevention-and-treatment-of-osteoporosis"},{"name":"The use of bisphosphonates in postmenopausal women with osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-use-of-bisphosphonates-in-postmenopausal-women-with-osteoporosis"},{"name":"Treatment of osteoporosis in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-osteoporosis-in-men"},{"name":"Use of biochemical markers of bone turnover in osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=use-of-biochemical-markers-of-bone-turnover-in-osteoporosis"},{"name":"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment"}]},{"name":"Other","type":"SUBSECTION","items":[{"name":"Antiepileptic drugs and bone disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=antiepileptic-drugs-and-bone-disease"},{"name":"Bone physiology and biochemical markers of bone turnover","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-physiology-and-biochemical-markers-of-bone-turnover"},{"name":"Drugs that affect bone metabolism","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=drugs-that-affect-bone-metabolism"},{"name":"Evaluation and treatment of low bone mass in primary biliary cholangitis (primary biliary cirrhosis)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=evaluation-and-treatment-of-low-bone-mass-in-primary-biliary-cholangitis-primary-biliary-cirrhosis"},{"name":"Medical consultation for patients with hip fracture","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=medical-consultation-for-patients-with-hip-fracture"},{"name":"Metabolic bone disease in inflammatory bowel disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=metabolic-bone-disease-in-inflammatory-bowel-disease"},{"name":"Normal skeletal development and regulation of bone formation and resorption","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=normal-skeletal-development-and-regulation-of-bone-formation-and-resorption"},{"name":"Osteonecrosis (avascular necrosis of bone)","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=osteonecrosis-avascular-necrosis-of-bone"}]},{"name":"Paget disease","type":"SUBSECTION","items":[{"name":"Clinical manifestations and diagnosis of Paget disease of bone","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=clinical-manifestations-and-diagnosis-of-paget-disease-of-bone"},{"name":"Treatment of Paget disease of bone","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-paget-disease-of-bone"}]},{"name":"Renal osteodystrophy","type":"SUBSECTION","items":[{"name":"Bone biopsy and the diagnosis of renal osteodystrophy","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=bone-biopsy-and-the-diagnosis-of-renal-osteodystrophy"},{"name":"Management of hyperphosphatemia in chronic kidney disease","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=management-of-hyperphosphatemia-in-chronic-kidney-disease"},{"name":"Refractory hyperparathyroidism and indications for parathyroidectomy in dialysis patients","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=refractory-hyperparathyroidism-and-indications-for-parathyroidectomy-in-dialysis-patients"}]},{"name":"Treatment","type":"SUBSECTION","items":[{"name":"Calcitonin in the prevention and treatment of osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=calcitonin-in-the-prevention-and-treatment-of-osteoporosis"},{"name":"Calcium and vitamin D supplementation in osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=calcium-and-vitamin-d-supplementation-in-osteoporosis"},{"name":"Epidemiology and etiology of osteoporosis in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=epidemiology-and-etiology-of-osteoporosis-in-men"},{"name":"Overview of the management of osteoporosis in postmenopausal women","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-the-management-of-osteoporosis-in-postmenopausal-women"},{"name":"Risks of bisphosphonate therapy in patients with osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=risks-of-bisphosphonate-therapy-in-patients-with-osteoporosis"},{"name":"The use of bisphosphonates in postmenopausal women with osteoporosis","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=the-use-of-bisphosphonates-in-postmenopausal-women-with-osteoporosis"},{"name":"Treatment of osteoporosis in men","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=treatment-of-osteoporosis-in-men"},{"name":"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment"}]},{"name":"Vitamin D","type":"SUBSECTION","items":[{"name":"Causes of vitamin D deficiency and resistance","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=causes-of-vitamin-d-deficiency-and-resistance"},{"name":"Overview of vitamin D","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=overview-of-vitamin-d"},{"name":"Vitamin D and extraskeletal health","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vitamin-d-and-extraskeletal-health"},{"name":"Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment","type":"TOPIC","languageCode":"EN","url":"topic.htm?path=vitamin-d-deficiency-in-adults-definition-clinical-manifestations-and-treatment"}]}]}